\documentclass[11pt,twoside]{article}\makeatletter

\IfFileExists{xcolor.sty}%
  {\RequirePackage{xcolor}}%
  {\RequirePackage{color}}
\usepackage{colortbl}
\usepackage{wrapfig}
\usepackage{ifxetex}
\ifxetex
  \usepackage{fontspec}
  \usepackage{xunicode}
  \catcode`⃥=\active \def⃥{\textbackslash}
  \catcode`❴=\active \def❴{\{}
  \catcode`❵=\active \def❵{\}}
  \def\textJapanese{\fontspec{Noto Sans CJK JP}}
  \def\textChinese{\fontspec{Noto Sans CJK SC}}
  \def\textKorean{\fontspec{Noto Sans CJK KR}}
  \setmonofont{DejaVu Sans Mono}
  
\else
  \IfFileExists{utf8x.def}%
   {\usepackage[utf8x]{inputenc}
      \PrerenderUnicode{–}
    }%
   {\usepackage[utf8]{inputenc}}
  \usepackage[english]{babel}
  \usepackage[T1]{fontenc}
  \usepackage{float}
  \usepackage[]{ucs}
  \uc@dclc{8421}{default}{\textbackslash }
  \uc@dclc{10100}{default}{\{}
  \uc@dclc{10101}{default}{\}}
  \uc@dclc{8491}{default}{\AA{}}
  \uc@dclc{8239}{default}{\,}
  \uc@dclc{20154}{default}{ }
  \uc@dclc{10148}{default}{>}
  \def\textschwa{\rotatebox{-90}{e}}
  \def\textJapanese{}
  \def\textChinese{}
  \IfFileExists{tipa.sty}{\usepackage{tipa}}{}
\fi
\def\exampleFont{\ttfamily\small}
\DeclareTextSymbol{\textpi}{OML}{25}
\usepackage{relsize}
\RequirePackage{array}
\def\@testpach{\@chclass
 \ifnum \@lastchclass=6 \@ne \@chnum \@ne \else
  \ifnum \@lastchclass=7 5 \else
   \ifnum \@lastchclass=8 \tw@ \else
    \ifnum \@lastchclass=9 \thr@@
   \else \z@
   \ifnum \@lastchclass = 10 \else
   \edef\@nextchar{\expandafter\string\@nextchar}%
   \@chnum
   \if \@nextchar c\z@ \else
    \if \@nextchar l\@ne \else
     \if \@nextchar r\tw@ \else
   \z@ \@chclass
   \if\@nextchar |\@ne \else
    \if \@nextchar !6 \else
     \if \@nextchar @7 \else
      \if \@nextchar (8 \else
       \if \@nextchar )9 \else
  10
  \@chnum
  \if \@nextchar m\thr@@\else
   \if \@nextchar p4 \else
    \if \@nextchar b5 \else
   \z@ \@chclass \z@ \@preamerr \z@ \fi \fi \fi \fi
   \fi \fi  \fi  \fi  \fi  \fi  \fi \fi \fi \fi \fi \fi}
\gdef\arraybackslash{\let\\=\@arraycr}
\def\@textsubscript#1{{\m@th\ensuremath{_{\mbox{\fontsize\sf@size\z@#1}}}}}
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\def\abbr{}
\def\corr{}
\def\expan{}
\def\gap{}
\def\orig{}
\def\reg{}
\def\ref{}
\def\sic{}
\def\persName{}\def\name{}
\def\placeName{}
\def\orgName{}
\def\textcal#1{{\fontspec{Lucida Calligraphy}#1}}
\def\textgothic#1{{\fontspec{Lucida Blackletter}#1}}
\def\textlarge#1{{\large #1}}
\def\textoverbar#1{\ensuremath{\overline{#1}}}
\def\textquoted#1{‘#1’}
\def\textsmall#1{{\small #1}}
\def\textsubscript#1{\@textsubscript{\selectfont#1}}
\def\textxi{\ensuremath{\xi}}
\def\titlem{\itshape}
\newenvironment{biblfree}{}{\ifvmode\par\fi }
\newenvironment{bibl}{}{}
\newenvironment{byline}{\vskip6pt\itshape\fontsize{16pt}{18pt}\selectfont}{\par }
\newenvironment{citbibl}{}{\ifvmode\par\fi }
\newenvironment{docAuthor}{\ifvmode\vskip4pt\fontsize{16pt}{18pt}\selectfont\fi\itshape}{\ifvmode\par\fi }
\newenvironment{docDate}{}{\ifvmode\par\fi }
\newenvironment{docImprint}{\vskip 6pt}{\ifvmode\par\fi }
\newenvironment{docTitle}{\vskip6pt\bfseries\fontsize{22pt}{25pt}\selectfont}{\par }
\newenvironment{msHead}{\vskip 6pt}{\par}
\newenvironment{msItem}{\vskip 6pt}{\par}
\newenvironment{rubric}{}{}
\newenvironment{titlePart}{}{\par }

\newcolumntype{L}[1]{){\raggedright\arraybackslash}p{#1}}
\newcolumntype{C}[1]{){\centering\arraybackslash}p{#1}}
\newcolumntype{R}[1]{){\raggedleft\arraybackslash}p{#1}}
\newcolumntype{P}[1]{){\arraybackslash}p{#1}}
\newcolumntype{B}[1]{){\arraybackslash}b{#1}}
\newcolumntype{M}[1]{){\arraybackslash}m{#1}}
\definecolor{label}{gray}{0.75}
\def\unusedattribute#1{\sout{\textcolor{label}{#1}}}
\DeclareRobustCommand*{\xref}{\hyper@normalise\xref@}
\def\xref@#1#2{\hyper@linkurl{#2}{#1}}
\begingroup
\catcode`\_=\active
\gdef_#1{\ensuremath{\sb{\mathrm{#1}}}}
\endgroup
\mathcode`\_=\string"8000
\catcode`\_=12\relax

\usepackage[a4paper,twoside,lmargin=1in,rmargin=1in,tmargin=1in,bmargin=1in,marginparwidth=0.75in]{geometry}
\usepackage{framed}

\definecolor{shadecolor}{gray}{0.95}
\usepackage{longtable}
\usepackage[normalem]{ulem}
\usepackage{fancyvrb}
\usepackage{fancyhdr}
\usepackage{graphicx}
\usepackage{marginnote}

\renewcommand{\@cite}[1]{#1}


\renewcommand*{\marginfont}{\itshape\footnotesize}

\def\Gin@extensions{.pdf,.png,.jpg,.mps,.tif}

  \pagestyle{fancy}

\usepackage[pdftitle={Optimizing Hyaluronic Acid: A Comprehensive Review of Rheological Insights for Clinical Practice},
 pdfauthor={}]{hyperref}
\hyperbaseurl{}

	 \paperwidth210mm
	 \paperheight297mm
              
\def\@pnumwidth{1.55em}
\def\@tocrmarg {2.55em}
\def\@dotsep{4.5}
\setcounter{tocdepth}{3}
\clubpenalty=8000
\emergencystretch 3em
\hbadness=4000
\hyphenpenalty=400
\pretolerance=750
\tolerance=2000
\vbadness=4000
\widowpenalty=10000

\renewcommand\section{\@startsection {section}{1}{\z@}%
     {-1.75ex \@plus -0.5ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large\bfseries}}
\renewcommand\subsection{\@startsection{subsection}{2}{\z@}%
     {-1.75ex\@plus -0.5ex \@minus- .2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large}}
\renewcommand\subsubsection{\@startsection{subsubsection}{3}{\z@}%
     {-1.5ex\@plus -0.35ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\large}}
\renewcommand\paragraph{\@startsection{paragraph}{4}{\z@}%
     {-1ex \@plus-0.35ex \@minus -0.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\normalsize}}
\renewcommand\subparagraph{\@startsection{subparagraph}{5}{\parindent}%
     {1.5ex \@plus1ex \@minus .2ex}%
     {-1em}%
     {\reset@font\normalsize\bfseries}}


\def\l@section#1#2{\addpenalty{\@secpenalty} \addvspace{1.0em plus 1pt}
 \@tempdima 1.5em \begingroup
 \parindent \z@ \rightskip \@pnumwidth 
 \parfillskip -\@pnumwidth 
 \bfseries \leavevmode #1\hfil \hbox to\@pnumwidth{\hss #2}\par
 \endgroup}
\def\l@subsection{\@dottedtocline{2}{1.5em}{2.3em}}
\def\l@subsubsection{\@dottedtocline{3}{3.8em}{3.2em}}
\def\l@paragraph{\@dottedtocline{4}{7.0em}{4.1em}}
\def\l@subparagraph{\@dottedtocline{5}{10em}{5em}}
\@ifundefined{c@section}{\newcounter{section}}{}
\@ifundefined{c@chapter}{\newcounter{chapter}}{}
\newif\if@mainmatter 
\@mainmattertrue
\def\chaptername{Chapter}
\def\frontmatter{%
  \pagenumbering{roman}
  \def\thechapter{\@roman\c@chapter}
  \def\theHchapter{\roman{chapter}}
  \def\thesection{\@roman\c@section}
  \def\theHsection{\roman{section}}
  \def\@chapapp{}%
}
\def\mainmatter{%
  \cleardoublepage
  \def\thechapter{\@arabic\c@chapter}
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \pagenumbering{arabic}
  \setcounter{secnumdepth}{6}
  \def\@chapapp{\chaptername}%
  \def\theHchapter{\arabic{chapter}}
  \def\thesection{\@arabic\c@section}
  \def\theHsection{\arabic{section}}
}
\def\backmatter{%
  \cleardoublepage
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \setcounter{secnumdepth}{2}
  \def\@chapapp{\appendixname}%
  \def\thechapter{\@Alph\c@chapter}
  \def\theHchapter{\Alph{chapter}}
  \appendix
}
\newenvironment{bibitemlist}[1]{%
   \list{\@biblabel{\@arabic\c@enumiv}}%
       {\settowidth\labelwidth{\@biblabel{#1}}%
        \leftmargin\labelwidth
        \advance\leftmargin\labelsep
        \@openbib@code
        \usecounter{enumiv}%
        \let\p@enumiv\@empty
        \renewcommand\theenumiv{\@arabic\c@enumiv}%
	}%
  \sloppy
  \clubpenalty4000
  \@clubpenalty \clubpenalty
  \widowpenalty4000%
  \sfcode`\.\@m}%
  {\def\@noitemerr
    {\@latex@warning{Empty `bibitemlist' environment}}%
    \endlist}

\def\tableofcontents{\section*{\contentsname}\@starttoc{toc}}
\parskip0pt
\parindent1em
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\newenvironment{reflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemsep}{0pt}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\itshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{sansreflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\itemsep}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\upshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{specHead}[2]%
 {\vspace{20pt}\hrule\vspace{10pt}%
  \phantomsection\label{#1}\markright{#2}%

  \pdfbookmark[2]{#2}{#1}%
  \hspace{-0.75in}{\bfseries\fontsize{16pt}{18pt}\selectfont#2}%
  }{}
      \def\TheFullDate{1970-01-01 (revised: 01 January 1970)}
\def\TheID{\makeatother }
\def\TheDate{1970-01-01}
\title{Optimizing Hyaluronic Acid: A Comprehensive Review of Rheological Insights for Clinical Practice}
\author{}\makeatletter 
\makeatletter
\newcommand*{\cleartoleftpage}{%
  \clearpage
    \if@twoside
    \ifodd\c@page
      \hbox{}\newpage
      \if@twocolumn
        \hbox{}\newpage
      \fi
    \fi
  \fi
}
\makeatother
\makeatletter
\thispagestyle{empty}
\markright{\@title}\markboth{\@title}{\@author}
\renewcommand\small{\@setfontsize\small{9pt}{11pt}\abovedisplayskip 8.5\p@ plus3\p@ minus4\p@
\belowdisplayskip \abovedisplayskip
\abovedisplayshortskip \z@ plus2\p@
\belowdisplayshortskip 4\p@ plus2\p@ minus2\p@
\def\@listi{\leftmargin\leftmargini
               \topsep 2\p@ plus1\p@ minus1\p@
               \parsep 2\p@ plus\p@ minus\p@
               \itemsep 1pt}
}
\makeatother
\fvset{frame=single,numberblanklines=false,xleftmargin=5mm,xrightmargin=5mm}
\fancyhf{} 
\setlength{\headheight}{14pt}
\fancyhead[LE]{\bfseries\leftmark} 
\fancyhead[RO]{\bfseries\rightmark} 
\fancyfoot[RO]{}
\fancyfoot[CO]{\thepage}
\fancyfoot[LO]{\TheID}
\fancyfoot[LE]{}
\fancyfoot[CE]{\thepage}
\fancyfoot[RE]{\TheID}
\hypersetup{citebordercolor=0.75 0.75 0.75,linkbordercolor=0.75 0.75 0.75,urlbordercolor=0.75 0.75 0.75,bookmarksnumbered=true}
\fancypagestyle{plain}{\fancyhead{}\renewcommand{\headrulewidth}{0pt}}

\date{}
\usepackage{authblk}

\providecommand{\keywords}[1]
{
\footnotesize
  \textbf{\textit{Index terms---}} #1
}

\usepackage{graphicx,xcolor}
\definecolor{GJBlue}{HTML}{273B81}
\definecolor{GJLightBlue}{HTML}{0A9DD9}
\definecolor{GJMediumGrey}{HTML}{6D6E70}
\definecolor{GJLightGrey}{HTML}{929497} 

\renewenvironment{abstract}{%
   \setlength{\parindent}{0pt}\raggedright
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
   \textcolor{GJBlue}{\large\bfseries\abstractname\space}
}{%   
   \vskip8pt
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
}

\usepackage[absolute,overlay]{textpos}

\makeatother 
      \usepackage{lineno}
      \linenumbers
      
\begin{document}

             \author[1]{Antony de Paula  Barbosa,}

             \author[2]{Juliana do Carmo  Públio}

             \author[3]{Isabela  Espasandin}

             \author[4]{Fernanda Lacerda de Almeida Romanó  Peixoto,}

             \author[5]{Paulo Henrique  Bastos}

             \affil[1]{  Instituto Antony Barbosa}

\renewcommand\Authands{ and }

\date{\small \em Received: 1 January 1970 Accepted: 1 January 1970 Published: 1 January 1970}

\maketitle


\begin{abstract}
        


The aging process of the face is characterized by transformations in the skin, bone, and adipose tissue. As the understanding of these changes has expanded, so too has the range of available filler products in the market. To maximize the effectiveness of hyaluronic acid, it is crucial to have a comprehensive understanding of its rheological properties. The numerous commercially available brands of hyaluronic acid differ in several aspects, such as the purity of their raw materials, methods of manufacturing, concentration of hyaluronic acid, presence and level of cross-linking, and ability to provide volume and withstand degradation. Aiming at the most assertive use of this product, features as viscosity (?), complex modulus (G*), elastic modulus (G"), tan d, cross-linking, concentration and swelling factor must be addressed, correlating them with their expected clinical effects.

\end{abstract}


\keywords{cohesiveness, extrusion force, hyaluronic acid, rheology, skin quality improvement, swelling degree.}

\begin{textblock*}{18cm}(1cm,1cm) % {block width} (coords) 
\textcolor{GJBlue}{\LARGE Global Journals \LaTeX\ JournalKaleidoscope\texttrademark}
\end{textblock*}

\begin{textblock*}{18cm}(1.4cm,1.5cm) % {block width} (coords) 
\textcolor{GJBlue}{\footnotesize \\ Artificial Intelligence formulated this projection for compatibility purposes from the original article published at Global Journals. However, this technology is currently in beta. \emph{Therefore, kindly ignore odd layouts, missed formulae, text, tables, or figures.}}
\end{textblock*}


\begin{textblock*}{10cm}(1.05cm,3cm)
{{\textit{CrossRef DOI of original article:}} \underline{}}
\end{textblock*}\let\tabcellsep& 	 	 		 
\section[{Introduction}]{Introduction}\par
ncreased understanding of facial aging has led to the introduction of several products for aesthetic use. Hyaluronic acid (HA) -based fillers have expanded in proportion to knowledge in availability and manufacturer diversity.\par
HA fillers currently account for about 80\% of all fillers used for rejuvenation and volume correction \hyperref[b0]{[1]}. These products have low complication rates, good durability, are relatively inexpensive, may be broken or degraded through a mechanism of enzymatic action (lysis) by injection of hyaluronidase \hyperref[b0]{[1,}\hyperref[b3]{4,}\hyperref[b5]{6]}.\par
HA is a natural linear polysaccharide of high viscosity and high molecular weight, found in the extracellular matrix, vitreous humor, and cartilage \hyperref[b3]{[4,}\hyperref[b12]{13,}\hyperref[b16]{17]}. Its total amount in a 70 kg individual is approximately 15 g, and its average turnover rate is 5 g/d. Approximately, 50\% of its amount in the human body is concentrated in the skin and has a half-life of 24-48 hours. The natural process of degradation involves mainly two mechanisms: enzymatic degradation and degradation by free radical action \hyperref[b3]{[4,}\hyperref[b12]{13]}.\par
Molecule of HA consists of alternating units of N-acetyl-D-glucosamine and glucuronic acid. This molecule is part of almost every tissue in vertebrates. Chemically, it is a hydrophilic macromolecule with -COOH and -OH functional groups (hydroxyl and carbosyl group). Its solubility in water is high, and it forms highly viscous solutions. In physiological conditions, the carboxyl group (-COOH) interacts with sodium ion (Na+) \hyperref[b3]{[4]}, attracting water molecules, so it is considered a hygroscopic molecule, so crossconnections formed the reticulation of the molecule, expanding according to its absorption of water. From this phenomenon the viscoelasticity occurs \hyperref[b27]{[28]}.\par
The functional group -OH (hydroxyl) is linked to the GLCNac anomeric carbon that donates a proton (H+) to -OH from the GLCA anomeric carbon (C1), and thus the C1 OH is now positively loaded oxygen and oxygen C3 is negatively charged, he attacks carbon C1 and releases H2O, thus forming the HA disaccharide (Figure  {\ref 1}. HA is a linear macromolecule composed of repeating disaccharide units) \hyperref[b28]{[29]}. Such solutions show unique viscoelastic properties. It is synthesized by a class of integral membrane proteins known as HA synthases, which lengthen HA by repeated addition of glucuronic acid and N-acetyl-d-glucosamine groups to the growing sugar (Figure  {\ref 1}. HA is a linear macromolecule composed of repeating disaccharide units). They can form intramolecular hydrogen bonding, which leads to three-dimensional structures. HA can trap water within its structure and can form gels, which inside the body can provide flexibility to the animal tissue and lubrication the set of bundles surrounded by dense connective tissue, in muscular tissues. Its role in the body is strictly connected with its properties, it plays an important role in ECM (extracellular matrix) by several specific and non-specific interactions.\par
The role of HA usually depends on its molecular weight. For example, low weight HA is essential in healing and scar formation, whereas high molecular weight HA may support tissue integrity \hyperref[b19]{[20]}. It can be used in tissue repair because it is able to promote mesenchymal and epithelial cell migration and differentiation. It is also helpful for the growth of epithelial tissue cells, eosinophil, macrophages, and a few animal tissues cells \hyperref[b19]{[20,}\hyperref[b26]{27]}. Biological properties make it very good material for tissue engineering \hyperref[b19]{[20]}.\par
Figure  {\ref 1}: HA is a linear macromolecule composed of repeating disaccharide units. Each disaccharide unit consists of two sugar molecules: glucuronic acid (C1) and N-acetylglucosamine (C3 and C4), represented in brackets. The chemical bonds between units are called glycosidic bonds, which occur between carbon 1 (C1) of one unit and carbon 4 (C4) of the next unit. The molecular structure of HA is highly hydrophilic, meaning it has a natural affinity for water. This is because of the functional hydroxyl groups (-OH) and carboxyl groups (-COOH), which are highly polar, meaning they have an unequal distribution of electrical charge, with a partial positive charge on hydrogen and a partial negative charge on oxygen and carbon. Water is also a polar molecule, with an uneven distribution of electrical charge due to its H2O structure. The hydrogen atoms in the water molecule have a partial positive charge, while the oxygen atom has a partial negative charge. This polarity causes water molecules to interact attractively with HA molecules. Hyaluronidase is an enzyme naturally present in the human body that breaks glycosidic bonds in HA. It acts by cleaving the ?(1?4) bonds between disaccharide units, converting HA from its viscous, high-molecularweight form into lower-molecular-weight fragments. 
\section[{a) The structure of the skin and forces acting on HA fillers}]{a) The structure of the skin and forces acting on HA fillers}\par
The skin has many vital functions, including protection against external physical, chemical and biological aggressors, as well as preventing the body from excessive water loss and a role in thermoregulation \hyperref[b14]{[15]}. The integumentary system is formed by the skin and its derived structures, divided in three layers: the epidermis, the dermis, and the subcutaneous tissue. These layers are referred to as an epidermis of stratified squamous epithelium, a basement membrane zone (BMZ) and a fibrous neurovascular dermis which supports on a hypodermis or subcutaneous fat \hyperref[b15]{[16]}.\par
At the outermost level, the epidermis is mainly composed of sheets of keratinocytes (Figure \hyperref[fig_1]{2}. Skin Structure and Appendages) but also contains nonepithelial cells, including antigen-presenting dendritic The middle layer, the dermis, is connective tissue itself which are the cells and the fibers that compose them. Such cells are: fibroblasts, fibrocytes, macrophages, lymphocytes, plasmocytes, mast cells and adipose cells. Its papillary layer is the most superficial and thin, made up of loose connective tissue. The reticular layer, deepest and thicker, consists of dense non-patterned connective tissue. The primary cell type is the fibroblast, which produces matrix extracellular structural proteins, glycosaminoglycans (which hydrate the tissue due to the high-water binding capacity of hyaluronic acid), collagen and elastin fibers (Figure \hyperref[fig_1]{2}. Skin Structure and Appendages). Both contain many fibers and elastic, responsible, in part, for the elasticity of the skin. In addition to blood and lymphatic vessels and nerves, the following structures are also found in the dermis: hair, sebaceous and sweat glands \hyperref[b20]{[21]}.\par
The Superficial Muscle Aponeurotic System (SMAS) connects the facial muscles to the dermis and aims to transmit, distribute and amplify the activity of all facial muscles. True ligaments are easily identifiable structures that connect the skin to the underlying periosteum (the membrane that covers the outer surface of the bone). And false retention ligaments are more diffuse condensations of fibrous tissue that connect the superficial and deep fascia to the skin \hyperref[b30]{[30]}. In muscle tissues, HA can retain water, which provides lubrication to the dense connective tissue (Epimysium, Perimysium, and Endomysium) that surrounds its fibers.\par
The hypodermis is situated within the subcutaneous tissue, primarily composed of loose connective tissue. It plays a crucial role in facilitating the smooth movement of the skin over the underlying structures. Depending on an individual's nutritional status and overall health, this layer may exhibit varying amounts of adipose tissue. Their consists of small clusters of fat cells known as adipocytes (Figure \hyperref[fig_1]{2}. Skin Structure and Appendages). The thickness of the subcutaneous layer can vary significantly depending on the specific anatomical location of the body \hyperref[b20]{[21]}.\par
After injection, the fillers are subjected to compression, shear, stretching, torsion by muscle movements, weight of soft tissue, pressure on external surfaces (e.g., face while sleeping), and gravitational force. All these forces modify the shape, distribution, time and the degree of correction of the filled defect (figure  {\ref 5}. This schematic representation illustrates the relationship between cohesiveness and viscosity in an HA gel, emphasizing their effects on the gel's behavior and shape when injected into the dermis and figure  {\ref 6}. Schematic representation of the cohesion and viscosity of an HA gel reveals a pivotal correlation). The gel's fluidity is greatly enhanced by its low viscosity and low cohesiveness, which results in a lack of unity. On the other hand, a gel that has low viscosity but high cohesiveness maintains its structural integrity while still remaining fluid. This balance also influences the level of force necessary to extrude the gel through a syringe and needle. When examining a filler with high viscosity and strong cohesiveness, it manifests as a denser and more cohesive gel, demanding greater force for extrusion. Conversely, in the absence of cohesiveness, the gel fails to maintain its unity after being injected into the dermis. In summary, the delicate balance between viscosity and cohesiveness significantly influences both the physical properties of the gel and its performance during injection, shaping the final outcome in dermal applications) \hyperref[b0]{[1,}\hyperref[b10]{11]}.\par
Considering the previous statement, depending on the region of the face where the HA is implanted, it will be submitted to 2 types of forces, each one causing a product deformation in a different plane. The first, in a horizontal plane parallel to the skin surface, is the shear or torsion force. The second, which is the compression/stretching force, is applied in a vertical plane perpendicular to the surface. Mechanical facial strains involve a combination of these 2 types of forces, and depending on the region in concern, one type of strain may be predominant (Figure \hyperref[fig_2]{3}. Dynamic forces of the HA in different planes of the dermis) \hyperref[b12]{[13,}\hyperref[b13]{14]}. To what extent these forces act on the product depends on several factors, such as the plane of injection (i.e., superficial versus deep) and anatomical location. Although the indications and instructions for use by the manufacturer are important, the skills required to create an aesthetic effect is dependent on the accuracy of the person performing the facial analysis and performing the filler \hyperref[b18]{[19]}. 
\section[{b) The Rheology versus its applications}]{b) The Rheology versus its applications}\par
Rheology is a section of mechanics which studies the deformation and flow of matter, particularly in light of its limits of resistance to deformation. Introducing this concept is important to understand the application of HA from the perspective of this property, as will be listed and explained below.\par
Understanding the rheological and biophysical fundamentals will result in clinical implications that facilitate the appropriate choice for Orofacial harmonization treatments \hyperref[b0]{[1,}\hyperref[b1]{2,}\hyperref[b9]{10]}. For example, the HA filler applied when the aim is to restore volume has different rheological characteristics from those indicated for the treatment of fine skin lines. Therefore, the fillers indicated for each aim and area will have different properties.\par
Several studies can provide insights into material behavior under different temperature stresses. Therefore, the study of a new formulation requires multiple steps to demonstrate safety, efficacy and stability to ensure consumer protection and satisfaction. During formulation of fillers, use and storage time, exposure to possible external factors such as physical damage, microbiological and chemical influences can.\par
These features influence the integration between the HA and the surrounding soft tissues and they determine the filler's ability to modify the anatomical layer volume, based on this statement, clinical planning can show different HA for different anatomical areas and even the same areas with different goals.\par
The objective of this study is to carry out a review on the rheology of HA fillers, characterizing and understanding the mechanical and viscoelastic properties of this polysaccharide in various contexts, including its concentration, temperature, and the presence of other components. This research will facilitate enhanced utilization of the product across a range of applications within tissue engineering and aesthetics area, leading to more effective and personalized clinical applications. As we delve deeper into understanding hyaluronic acid and its role in facial harmonization, the subsequent sections of this article will explore various aspects, starting with the manufacturing technology, followed by an examination of its physical-chemical properties and will culminate in a detailed exploration of its rheological features. These sections collectively shed light on the multifaceted aspects of HA-based fillers and their applications in clinical practice. 
\section[{II.}]{II.} 
\section[{Manufacturing Technology}]{Manufacturing Technology}\par
HA is made naturally in the human body, has a half-free radical action. For this reason, the HA used as a filler needs to be modified through a process called crosslinking. HA fillers differ in their manufacturing technologies, formulations, additives, and clinical indications \hyperref[b1]{[2]}. The HA used for the manufacture of fillers is mainly produced with biotechnology, from the fermentation of microorganisms, such as the genus of Streptococcus aerobic bacteria. This is biocompatible with the human body, as the structure of HA is highly conserved in different species \hyperref[b7]{[8]}. Bacterial fermentation produces noncrosslinked HA of varying lengths. HA chains must undergo a stabilization process to avoid rapid enzymatic and oxidative HA 9 adapted resorption \hyperref[b0]{[1,}\hyperref[b3]{4,}\hyperref[b7]{8]}. To achieve this goal, the HA polymerization is enhanced by a crosslinking process that adds a molecule, called BDDE (1,4-butanediol diglycidyl ether) linking the polymer chains to each other \hyperref[b0]{[1,}\hyperref[b3]{4,}\hyperref[b16]{17,}\hyperref[b17]{18]} (Figure \hyperref[fig_2]{3}. Dynamic forces of the HA in different planes of the dermis). BDDE is the crosslinking agent with the lowest toxicity, its amount is limited by the FDA (Food and Drug Administration) to a residual level of unreacted BDDE <2 parts per million (ppm) \hyperref[b0]{[1]}. BDPE, which stands for "1,4-butanediol di-(propan-2,3-diolyl)ether," is derivatives formed throuth of nucleophiles during the cross-linking process the epoxide groups of BDDE. This results in the formation of a three-dimensional network that prevents rapid dissolution to improve the mechanical and physical properties. This processes, crosslinking significantly reduces the rate at which the body metabolizes the filler, prolonging its presence in the treated area. This results in longer-lasting effects and improved structural support. Additionally, crosslinked fillers are better equipped to resist degradation, maintaining their shape and volume over time. Crosslinked HA has been used for over 15 years and it is well tolerated. It has structural properties similar to native tissue, excellent biocompatibility and good integration \hyperref[b1]{[2,}\hyperref[b0]{1]}]. Over time, unreacted BDDE is degraded through hydrolysis \hyperref[b3]{[4]}.\par
Crosslinked HA has structural properties similar to native tissue, excellent biocompatibility and good integration. In areas where long-lasting results are desired, such as the midface or temples, fillers with higher cross-linking are preferred \hyperref[b3]{[4]}.\par
Hyaluronidase naturally occurs in various organs (such as the testis, spleen, skin, eyes, liver, kidneys, uterus, and placenta) and body fluids (tears, blood, and semen). There are six known types of hyaluronidase (hyaluronidase 1-4, PH-20, and HYALP1). Hyaluronidase 1, encoded by the HYAL1 gene, is prevalent in major organs Figure  {\ref 4}: This schematic representation illustrates the differences between natural, cross-linked HA and the process of physical crosslinking. Natural HA: represented by the blue line as a linear molecule composed of repeating disaccharide units. Cross-Linked HA: represented by the blue line connected by the orange, at higher magnification, in which there are additional, BDDE ou BDPE connecting bonds between HA chains. These bonds, often formed through chemical processes, create a network or matrix. Crosslinking enhances the stability and longevity of HA fillers when used for cosmetic purposes. The degree of cross-linking can vary, influencing the gel's cohesiveness and resistance to degradation. Physical Crosslinking: is a technique that allows for HA modification without the use of chemical agents, such as changes in temperature, pH, or the application of external forces to induce cross-linking.\par
However, the natural linear form of HA molecules is susceptible to rapid degradation by hyaluronidase, rendering it unsuitable as a filler due to its inadequate consistency and short half-life. To overcome this limitation, it is essential to modify the physical properties of HA to increase its resistance to in vivo degradation \hyperref[b6]{[7]}. In practice, dermal HA is composed of both unmodified HA (without crosslink) and crosslinked HA (with crosslink), forming a polymeric network that achieves the desired durability and stability \hyperref[b5]{[6,}\hyperref[b6]{7]}.\par
Unlike the linear polymer, the crosslinked network is able to swell in aqueous media without dissolving, it behaves rheologically as a gel-like material, shows a viscosity that decreases with shear rate under flow conditions, and it is less sensitive to degradation by hyaluronidase. It thus gives the injected HA gel hydration, projection (filler effect), injectability, and a longer tissue permanence than linear HA \hyperref[b17]{[18]}.\par
Production methods are used to alter the molecular technologies available on the market with their respective manufacturers, indications for use, type of filler marketed, and HA concentration (mg/ml) \hyperref[b10]{[11,}\hyperref[b18]{19]}. The technology manufacturing too will influence in the action of the natural hyaluronidase, to action order for it to dissolve a HA filler, it must be able to access the intramolecular bonds. Interfer in this access include the number of crosslinks and the concentration of HA. The more crosslinking, the more difficult it is for hyaluronidase to access its binding inside the HA filler. For this reason, fillers with high crosslinking require a long time to dissolve with by this enzyme action. In addition, the higher the concentration of HA, the slower it will be dissolved by hyaluronidase \hyperref[b21]{[22]}.\par
It is important to remember that the hyaluronic acid gel will always be degraded by the action of the hyaluronidase enzyme, and it is important to pay attention to the amount of hyaluronic acid injected versus the dose of hyaluronidase, which can directly determine the final degradation time of the product (dose-dependent responses).Its use has safety implications in the context of HA filler procedures. It serves as an important tool in managing filler-related complications, such as overcorrection or vascular occlusion. However, its use must be carefully considered and administered by trained professionals to minimize potential risks, including allergic reactions or tissue damage \hyperref[b22]{[23]}.\par
Manufacturing parameters such as high temperatures and strong acidic and alkali pH are sensitive for the HA chains. Indeed, the usual manufacturing conditions (heat, alkali pH, and sterilization) are prone to degrade HA gels and release low-Mw soluble HA (sHA) \hyperref[b10]{[11]}. Therefore, it is necessary to explain the manufacturing processes available. XpresHAn technology, which has varying degrees of crosslinking to provide different levels of flexibility and support while maintaining natural movement in areas of dynamic expression. The NASHA technology (Non Animal Stabilized Hyaluronic Acid) produces firmer gels based on molecular entanglements and small amounts of chemical crosslinking, with controlled particle sizes at   
\section[{Physical-chemical Properties}]{Physical-chemical Properties}\par
In the context of clinical orofacial harmonization procedures, understanding the composition and concentration of hyaluronic acid (HA) in dermal fillers is of paramount importance. Manufacturers often provide the total HA concentration in the gel, but they usually do not distinguish between the amount of insoluble crosslinked HA and soluble non-cross-linked HA within the biopolymer. The soluble portion of HA is intentionally included to optimize the filler's viscosity, making it easier to inject through a needle. It's worth noting that this soluble HA is readily metabolized by the body. As a result, the total concentration stated for commercially available fillers should be viewed as more of a reference value rather than an absolute measurement \hyperref[b0]{[1]}.\par
Soluble HA enhances the filler's viscosity, which makes it more fluid and easier to extrude through a needle during the injection process. This improved injectability allows for smoother and more precise placement of the filler in the target area. Also contributes to the initial volume of the filler, allowing it to provide immediate results in terms of volume enhancement and wrinkle reduction \hyperref[b0]{[1,}\hyperref[b33]{33,}\hyperref[b34]{34]}.\par
However, the presence of it also has implications for the longevity of the filler, because is easily metabolized by the body, which means that over time, may gradually break down and lose its volumeenhancing effects and this can vary from person to person but typically occurs over several months \hyperref[b13]{[14]}.\par
The ideal concentration of hyaluronic acid (HA) is 20mg/mL or higher. This concentration enables significant volume expansion when the filler is injected into the target tissue, resulting in a prolonged effect that enhances its structural integrity. Furthermore, it retards the rate at which the body metabolizes the filler. This concentration should demonstrate a viscosity that strikes a balance between ease injection for delivering  \hyperref[b24]{[25]}. Cohesive polydensified matrix (CPM) HA is also characterized by a higher mean molecular weight of non-cross-linked (soluble) HA than in other currently available products, the variable cross-linking is intended to confer resilience and retention of structural integrity \hyperref[b25]{[26]}.\par
Graph 1: This chart illustrates the advantages and disadvantages of using HMW-HA and LMW-HA in dermal fillers across various characteristics. The comparison covers factors such as effect, metabolism, filler duration, volumizing capacity, wrinkles filler, spreadability and consistency of the gel. HMW-HA offers extended longevity and robust structural support but may be less suitable for fine corrections. LMW-HA, on the other hand, excels in ease of spreading, making it ideal for fine lines and precise results. However, it tends to have a shorter duration and may require more frequent touch-up sessions.\par
This understanding of HA characteristics and concentration is crucial for clinicians aiming to achieve optimal results in facial harmonization and other aesthetic procedures.\par
IV. 
\section[{Rheological Features}]{Rheological Features}\par
Rheology, a subfield of physical chemistry, delves into the study of how different materials respond to deformation and flow, whether they are solid, semisolid, or liquid. It examines the ability of matter to maintain its shape, which is a defining characteristic of solids, and this property is known as stiffness. Stiffness is evaluated using elasticity, which measures a material's resistance to deformation. Hooke's law establishes a mathematical relationship between the To analyze a gel for injection into the skin layers the most main features are viscosity (?), complex modulus (G*), elastic modulus (G'), tan delta? (G''), cross-linking, concentration and the swelling factor (the absorption factor) \hyperref[b1]{[2,}\hyperref[b5]{6,}\hyperref[b6]{7,}\hyperref[b18]{19]}.\par
Fluids are shapeless, thus they are unable to resist deformation. They have an intrinsic and specific feature: viscosity (?). It can be defined as the ability of a fluid to resist flow \hyperref[b0]{[1,}\hyperref[b2]{3]}. This tells the pressure required to determine the flow of a fluid (for example: water and honey) \hyperref[b0]{[1]}.  Optimizing Hyaluronic Acid: A Comprehensive Review of Rheological Insights for Clinical Practice adequate support and structure to the treated area of the face \hyperref[b0]{[1,}\hyperref[b6]{7]}.\par
Therefore, this concentration it presents better cost-effectiveness, because can achieve the desired results with smaller volumes, patients may require less product, and clinicians can achieve their treatment goals with fewer syringes of filler. Then it offers a balance between ease of injection, longevity of results, and costeffectiveness \hyperref[b0]{[1,}\hyperref[b6]{7]}.\par
In clinical practice, dermal fillers primarily consist of high molecular weight HA (HMw). These fillers exhibit unique viscoelastic and biophysical properties based on their chemical compositions, including HA concentration, Mw of HA, and the specific crosslinker used in their formulation. The molecular weight of HA plays a pivotal role in providing structural and physicochemical integrity to the filler, and it directly influences its viscosity, in addition can influence how it behaves in various facial areas during injection \hyperref[b33]{[33]}. HMw and Low molecular weight HA represent two distinct options in dermal fillers. HMw HA offers several advantages, including its tendency to provide longerlasting results when compared to LMw fillers. It is metabolized more slowly by the body, contributing to its durability. Also offers robust structural support, effectively addressing deeper wrinkles and areas with volume loss and diminished tissue integrity. Additionally, it can promote tissue integrity by stimulating collagen production. On the other hand, LMw HA provides a more natural appearance and offers a softer and more fluid texture, making it particularly suitable for areas with fine lines and delicate contours. Furthermore, it facilitates easier injection and yields quicker results \hyperref[b34]{[34,}\hyperref[b34]{34]}.\par
Both also have disadvantages, as HMw HA fillers look less natural in the treated area due to their thicker consistency and have limited spreadability. While LMw HA fillers are less durable, they provide limited structural support and are metabolized more quickly. Therefore, the choice between HMw and LMw AH fillers depends on the patient's specific aesthetic goals and treatment area (graphic 1) \hyperref[b33]{[33,}\hyperref[b34]{34]}. elastic strength, stress applied, and deformation induced in a material. This understanding of rheology is fundamental in exploring how substances deform and flow \hyperref[b0]{[1,}\hyperref[b1]{2]}.\par
Viscosity is a measure of a fluid's resistance to flow. It determines how easily a substance flows or moves when subjected to an applied force. Liquids with high viscosity are thick and flow slowly, while those with low viscosity are thin and flow more easily. Viscosity is influenced by factors such as temperature and the internal friction of the fluid's molecules \hyperref[b11]{[12]}.\par
The viscosity of a dermal filler is related to the concentration of non-crosslinked and crosslinked HA, the degree of crosslinking, the molecular weight distribution, the average particle size of the gel, and the manufacturing process. It is crucial that hydrogels have low viscosity at high shear (100 s-1), so that they can be extruded through a small-caliber needle. High viscosity under low shear is in fact comparable to the condition of the hydrogel after injection or when resting in the package \hyperref[b11]{[12]}. If the viscosity is too high, the injection of the fillers becomes difficult to apply. Adding free HA reduces the viscosity, because hydration effect increases the overall viscosity of the filler, making it thicker and more gel-like, it trap water within its structure, lead to the formation of gels, enhances its volumizing capacity can influence the texture and consistency of the filler. However, professionals lack information on the amount of free HA present in the product (i.e. soluble and insoluble fractions). The total concentration of commercially available HA is a reference value, so this parameter is not absolute for assessing the filler's performance \hyperref[b12]{[13]}.\par
From a clinical perspective, it is crucial for these fillers to demonstrate low viscosity when subjected to high shear forces. This characteristic enables smooth extrusion through a fine-gauge needle during the injection process, ensuring precise and controlled injection in target tisues. This, in turn, reduces discomfort for the patient during the injection and facilitates even distribution of the filler. Achieving even distribution is essential for achieving natural-looking results, particularly in delicate facial areas.\par
Conversely, high viscosity under low shear conditions is like the state of the hydrogel within the product vial or after injection into the target area. This condition, after injection ensures that the filler maintains its shape and position over time, it provides structural support and volume, helping to lift and restore sagging or deflated areas of the face and minimized migration. Lower viscosity is often preferred, especially in areas with fine lines or where precise distribution is necessary, such as the lips or tear troughs. It allows for smoother and more controlled injection \hyperref[b12]{[13]}.\par
Complex viscosity is a crucial parameter that assesses the gel's capacity to withstand shear forces within a tissue following injection. In addition, the elastic modulus, another significant factor, gauges the hydrogel's inherent stiffness and its interactions with the surrounding environment. These parameters collectively influence the hydrogel's ability to effectively withstand the tensile forces exerted on it following injection, primarily arising from the dynamic movements of facial muscles \hyperref[b1]{[2,}\hyperref[b5]{6]}.\par
These last two parameters directly impact a gel's ability to endure the shear and tensile forces experienced within facial tissues post-injection.\par
The measure of the total energy needed to deform a material using shear stress is complex modulus, which indicates the overall resistance to deformation of a material, regardless of whether that deformation is recoverable (elastic) or non-recoverable (viscous). This measure is favorite to quantify the gel hardness, being it is a good indicator of projections in clinical applied, in which the stiffness or hardness of the HA filler has direct relation: the higher the magnitude of the complex modulus, the stiffer the material \hyperref[b30]{[30]}.\par
The complex modulus combines both elastic and viscous responses of a material to deformation. It is used to characterize a material's overall resistance to deformation, considering both its ability to return to its original shape (elastic behavior) and its tendency to flow or deform irreversibly (viscous behavior) when subjected to stress. It is particularly important in the study of materials' response to dynamic forces and shear stress. It is represented as a complex number, often in the form G* = G' + G'', where G' represents the elastic modulus and G'' represents the viscous modulus \hyperref[b30]{[30]}.\par
Typically, the clinical choice of G' is guided by the extent of correction needed and the treatment plan in place. In cases where a deeper injection plan is warranted to provide robust support for achieving a higher degree of correction, it is advisable to opt for hydrogels with a higher (firmer) G*. These firmer hydrogels excel in their corrective capacity when it comes to deep deposition and the creation of elevations or projections, especially in areas like the malar cheek, chin, and jaw, where they can be strategically placed against the bone for enhanced projection. In such The complex modulus, referred to as G*, is a comprehensive measure that takes into account both the elastic modulus (G') and viscosity modulus (G''). It's crucial to highlight that the filler material should strike a delicate equilibrium between its ability to be pliable, enabling it to flow smoothly through the needle, and its structural robustness, ensuring it retains its intended shape once it's injected into the soft tissues. The injection procedure itself comprises several distinct phases, starting with the material's passage through the needle and culminating in its seamless integration into the adjacent soft tissues. Therefore this filler needs to possess adequate malleability to navigate the needle without resistance while maintaining structural integrity to provide the desired cosmetic enhancement. This balance ensures a successful and aesthetically pleasing outcome. For precise sculpting in areas like the nose or jawline, higher G* values are beneficial, allowing for better control during injection \hyperref[b30]{[30]}. scenarios, they exhibit superior compressive strength, effectively countering the intrinsic forces within the deeper tissue planes \hyperref[b18]{[19]}.\par
On the other hand, if the injection plan involves shallower planes with less pronounced corrections, hydrogels with a lower G* (softer) can be a suitable choice. However, it's worth noting that these softer products can also be employed in deeper planes to achieve clinical effects when necessary. Additionally, they can be layered atop higher G* products to attain the desired outcome \hyperref[b18]{[19]}.\par
Elasticity, in the context of materials and mechanics, refers to the property of a substance to return to its original shape and size after it has been deformed or stretched \hyperref[b0]{[1,}\hyperref[b6]{7]}. attempt to push them through a needle, the gel with the higher G" will resist the flow more strongly and require more force to pass through the needle compared to the one with the lower G". This is because the higher G" indicates a greater ability of the gel to absorb and dissipate energy when subjected to strain, resulting in increased resistance to flow.\par
For professional, a higher G' value indicates that the material is stronger and less prone to deformation. A gel with a higher G" indicate heightened resistance is a result of the higher G", signifying the gel's greater ability to absorb and dissipate energy when subjected to strain. They must be aware of these G" values as they directly impact the ease and precision of material delivery during procedures (Figure5. This schematic representation illustrates the relationship between cohesiveness and viscosity in an HA gel, emphasizing their effects on the gel's behavior and shape when injected into the dermis.).\par
Tan delta (?) is the measure of the elasticity versus viscosity balance in the gel, and it is defined by G" and G' ratio. Gels characterized by a high (d), with values close to one, are predominantly viscous (e.g. honey), while those characterized by a low (d), with values close to zero, are predominantly elastic (e.g. gelatine) \hyperref[b6]{[7]}.\par
Swelling Factor (hydration capability) occurs due to the insoluble HA and the cross-linking degree can impair the penetration and binding of the water molecule \hyperref[b0]{[1]}. The expansion after injection adds the volumeizing effect \hyperref[b0]{[1,}\hyperref[b6]{7]} and, if excessive, it may lead to unwanted effects such as becoming palpable and edema \hyperref[b0]{[1,}\hyperref[b2]{3]}. In vivo swelling depends on the structure of the surrounding tissue, its fluid balance and pH value \hyperref[b4]{[5]}.\par
The closer to the equilibrium state of hydration (saturation) of a gel the smaller the swelling will be after injection. If below equilibrium (unsaturated), it will easily absorb water from the surrounding fluid until it reaches equilibrium. This feature varies from product to product and it depends on the hyaluronic acid concentration and the physical constraints imposed by the cross-linking. Usually, the higher the cross-linking and the G*, the lower the swelling factor \hyperref[b18]{[19]}.\par
This hydration capability is significant because it contributes to the volume-enhancing effect of the filler after injection. However, excessive swelling can result in unwanted side effects, including palpable lumps and edema. In vivo, the extent of swelling following injection is influenced by several factors. These include the structure of the surrounding tissue, the local fluid balance and the pH value of the environment. In cases where the gel is below equilibrium (unsaturated), it will readily absorb water from the surrounding fluid until it reaches the equilibrium state. This property is crucial in areas like the cheeks or nasolabial folds, in which can Elastic modulus (E) is the ratio between Stress (?) and Strain (?), in other words, it is the stress applied to the material over the strain that induced it. To better understand the concept of stress, if an external compressive force is applied in a solid its molecules are pushed together, and they accumulate a repulsive force. The internal pressure, determined by the repulsive force, is the stress. Therefore, stress is the internal pressure that material is subject to when external forces are applied and this is a measure of how much the dimension of an object has changed \hyperref[b0]{[1]}. In simpler terms, it quantifies how a material responds to an applied force and how much it deforms under that force. Practitioners need to consider how these materials respond to the forces applied during the injection process and how they behave within the target tissues (Figure  {\ref 7} Material Properties: Elasticity, Viscosity, and Viscoelasticity) \hyperref[b0]{[1,}\hyperref[b6]{7]}.\par
Elastic modulus (G') is a measure of the stored energy in a material in which shear deformation has been employed. In other words, it can be thought of as the proportion of the total stiffness (the complex modulus -G*) of a material that is attributable to elastic deformation. It represents the fraction of energy G' stored during deformation which can be used to recover its original shape when the deformation is removed. Combined, G' and G" define the complex modulus, or G*, which represents gel is resistant to deformation \hyperref[b0]{[1,}\hyperref[b6]{7,}\hyperref[b9]{10]}. With higher G*, the material is stronger and less deformable (Figure \hyperref[fig_2]{3}. Dynamic forces of the HA in different planes of the dermis and Figure  {\ref 5}. This schematic representation illustrates the relationship between cohesiveness and viscosity in an HA gel, emphasizing their effects on the gel's behavior and shape when injected into the dermis) \hyperref[b0]{[1]}.\par
Viscous modulus (G") represents the amount of energy that is absorbed by a substance when it experiences deformation \hyperref[b0]{[1,}\hyperref[b6]{7]}. A gel with a higher G" value is more viscous or thicker, which means it demands a greater amount of force to be extruded through a needle \hyperref[b6]{[7]}. For example, if we have two gels, one with a low G" and another with a high G", and we quickly restore volume in the cheeks, offering an instant rejuvenating effect \hyperref[b18]{[19]}.\par
Typically, a higher degree of cross-linking and a higher value of G* (complex modulus) result in a lower Swelling Factor. This means that products with strong cross-linking and higher G* values tend to exhibit less swelling after injection, which can be advantageous in clinical applications where precise control over volume enhancement and reduced risk of side effects are desired \hyperref[b24]{[25]}.\par
Figure  {\ref 5}: This schematic representation illustrates the relationship between cohesiveness and viscosity in an HA gel, emphasizing their effects on the gel's behavior and shape when injected into the dermis. A highly cohesive gel is represented with robust intermolecular connections, forming a structured network. In the dermis, cohesiveness ensures that the gel maintains its shape, doesn't excessively spread, and provides structural support, as the draw. The increased dermal projection can be observed in the graph. When viscosity is higher, the gel appears as thicker, while lower viscosity results in a more fluid consistency. Therefore plays a significant role in how the gel flows during injection and its ability to conform to dermal contours.\par
Figure  {\ref 6}: Schematic representation of the cohesion and viscosity of an HA gel reveals a pivotal correlation. The gel's fluidity is greatly enhanced by its low viscosity and low cohesiveness, which results in a lack of unity. On the other hand, a gel that has low viscosity but high cohesiveness maintains its structural integrity while still remaining fluid. This balance also influences the level of force necessary to extrude the gel through a syringe and needle. When examining a filler with high viscosity and strong cohesiveness, it manifests as a denser and more cohesive gel, demanding greater force for extrusion. Conversely, in the absence of cohesiveness, the gel fails to maintain its unity after being injected into the dermis. In summary, the delicate balance between viscosity and cohesiveness significantly influences both the physical properties of the gel and its performance during injection, shaping the final outcome in dermal applications.\par
Cohesiveness is described as the force between particles in the same substance that acts to bind them together \hyperref[b0]{[1,}\hyperref[b4]{5]}. In the case of fillers, cohesiveness is an expression of the internal adhesion forces that hold the individual crosslinked HA units together \hyperref[b24]{[25]} (Figure  {\ref 5}. This schematic representation illustrates the relationship between cohesiveness and viscosity in an HA gel, emphasizing their effects on the gel's behavior and shape when injected into the dermis and Figure  {\ref 6}. Schematic representation of the cohesion and viscosity of an HA gel reveals a pivotal correlation). A high cohesiveness simultaneously with a low viscosity accompanies homogeneous tissue integration \hyperref[b4]{[5]}. This property contributes to the natural and harmonious appearance of the treated area, such as lip enhancement, cheek contouring, and jawline definition. Less cohesive fillers may spread more easily, potentially causing uneven distribution or migration. In contrast, highly cohesive HA formulations are less prone to migration, reducing the likelihood of irregularities or asymmetry, which can be essential for achieving harmonious facial proportions.\par
Viscoelasticity is the capacity to undergo deformation up to a certain point when subjected to Optimizing Hyaluronic Acid: A Comprehensive Review of Rheological Insights for Clinical Practice shear stress and then return to its original shape once the force causing the deformation is removed (see Figure  {\ref 7}. Material Properties: Elasticity, Viscosity, and Viscoelasticity) \hyperref[b0]{[1,}\hyperref[b4]{5]}. Subsequently, the types of HA gels can be categorized based on their viscoelasticity and cohesiveness, factors that determine their resistance to mechanical stresses (their ability to flow slowly) and their capability to revert to their original form. Viscoelasticity primarily relates to resistance against deformation in the horizontal plane, such as lateral shear or torsion, whereas cohesiveness pertains to resistance in the vertical plane, encompassing compression and stretching \hyperref[b12]{[13,}\hyperref[b13]{14]}. In essence, it is the amalgamation of these properties that enables AH to be molded during application and, simultaneously, to preserve its shape and volume over time. However, when considering the elastic modulus, it clinically signifies the gel's rigidity and its capacity to maintain its shape post-injection. High viscoelasticity fillers are suitable for cheek augmentation, providing long-lasting volume and contouring \hyperref[b13]{[14]}.\par
Enhancing the polymer's molecular weight and degree of crosslinking has been a well-established approach to improve mechanical strength and prolonging degradation rates. Depending on its concentration and the extent of crosslinking, the product's shelf life can range between 6 to 18 months. Estimating the post-injection product duration is challenging, given its dependency on numerous factors including skin type, age, patient's lifestyle, the treated area, injection technique, and even aspects of the manufacturing process such as crosslinking \hyperref[b12]{[13]}.\par
The high degree of crosslinking too reduces the HA's hydrophilicity while increasing its hardness \hyperref[b3]{[4]}. The gel hardness relates to its resistance to be deformed. It varies with HA concentration, degree of crosslinking, and particle size. Usually, softer gels are suitable for filling surface layers and are generally not intended for lifting or greater volume, for which stiff gels are proposed \hyperref[b13]{[14]}.\par
Highly crosslinked HA gels with a high G' (elasticity) are recommended in situations where minimizing swelling is crucial. This is particularly important in regions where excessive water absorption might result in unfavorable outcomes or the formation of pockets, they are effective for volumizing the midface, as they provide sustained support and contouring. Than fillers should be used cautiously as they are stiff and not suitable for areas with significant motor skills \hyperref[b13]{[14]}.\par
Figure  {\ref 7}: Material Properties: Elasticity, Viscosity, and Viscoelasticity: An elastic material, depicted in the diagram in purple color, exhibits a property known as elasticity. After deformation, when a force is removed, the material promptly returns to its original shape and size. A viscous material, shown in the schematic in cyan color, lacks the elastic property of immediate shape recovery. Instead, it undergoes deformation when a force is applied, and when the force is removed, the material does not return to its original shape. Viscous materials, such as honey, flow continuously under the influence of an applied force. A viscoelastic material, depicted in the diagram in green color, exhibits a combination of both elastic and viscous properties. After deformation, it partially returns to its original shape over time when the force is removed. Understanding the properties helps predict how filler respond to deformation and stress.\par
The study of a new formulation requires multiple steps to demonstrate safety, efficacy, and stability to ensure consumer protection and satisfaction. During formulation of fillers, use and storage time, exposure to possible external factors such as physical damage, microbiological and chemical influences can lead to instability to varying degrees \hyperref[b11]{[12]}. For example, a thermal stress can change the product viscosity and the loss of storage modulus (Figure \hyperref[fig_2]{3}. Dynamic forces of the HA in different planes of the dermis). The rheological features influence the integration between the HA and the surrounding soft tissues and they determine the filler's ability to modify the anatomical layer volume, based on this statement, clinical planning can show different HA for different anatomical areas and even the same areas with different goals.\par
Dermal quality and the degree of correction necessary are references to choice what the product may be selected by G*, however, it is important to emphasize that G* is just one of the rheological characteristics of hyaluronic acid gel. These variables differ between patients, and their nature will determine what degrees of strength and firmness are appropriate for the filler. It is also important to consider how it will be injected for the best result, whether distributed or punctual. In consensus, products with lower G' is Optimizing Hyaluronic Acid: A Comprehensive Review of Rheological Insights for Clinical Practice usually more indicated, because they are softer and easier to distribute in the tissue, in thinner skin, where there is palpability/visibility \hyperref[b18]{[19]}.\par
Higher G' products are recommended for deeper injection plans, where they offer greater support and corrective capacity, especially in areas such as the malar cheek, chin, and jaw, where the product needs to be placed against bone for projection. On the other hand, lower G' products, which are softer, are typically used for shallower injection planes with less severe corrections. In areas where dynamic facial expressions play a significant role, such as around the mouth, lower G' products may be preferred. These softer fillers can accommodate the natural movement of the muscles without creating an overly rigid appearance. They provide a subtle enhancement while allowing for natural facial expressions. In some cases, a combination of lower G' and higher G' products may be used in layered injections to achieve a balanced and customized result. Ultimately, the choice of G' in dermal fillers, even in areas involving facial motricity, should be tailored to the specific needs and aesthetic goals of the patient, taking into consideration both the depth of injection and the dynamic nature of the facial muscles \hyperref[b18]{[19]}.\par
The delicate balance between flexibility and structural robustness in HA fillers is crucial for achieving natural-looking results and patient satisfaction. This balance plays a pivotal role, as it ensures that the filler integrates seamlessly into the dynamic facial tissues while providing the necessary support for the desired cosmetic enhancement \hyperref[b19]{[20]}.\par
Several advantages become apparent how natural-looking results, in which the flexibility allows the filler to adapt and move harmoniously with the facial expressions and muscle contractions; patient comfort, on that the flexibility reduce discomfort or sensations of tightness in the treated area; longevity and satisfaction are verify in robust HA, be can provide enduring support to the tissues, extending the duration of the results; the flexibility of HA fillers allows for versatility in addressing various aesthetic concerns, from fine lines to deep wrinkles and volume loss and reduction risk of overcorrection, are supported on right balance that ensures that the filler doesn't overcorrect or create unnatural contours \hyperref[b19]{[20]}.\par
HA fillers have varied considerably in terms of concentration, injection strength, particle size and rheological properties. These variations can result from the underlying technology used to create each filler, which in turn impacts its molecular structure and clinical performance \hyperref[b12]{[13]}. Therefore, practitioners rely on manufacturer's recommended indications when choosing fillers. However, rheological properties are measured under different conditions by different manufacturers. Nevertheless, this information is useful for choosing the type of acid according to your clinical need to obtain satisfactory results with minimal amounts of material.\par
V. 
\section[{Conclusion}]{Conclusion}\par
A key aspect of using HA in facial treatments is understanding its rheology, which influences product quantity and offers numerous benefits: In your journey in aesthetic area, remember that knowledge of HA filler rheology ensures safer, more cost-effective, and satisfying treatments for both practitioners and patients.\begin{figure}[htbp]
\noindent\textbf{2}\includegraphics[]{image-2.png}
\caption{\label{fig_1}Figure 2 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{3}\includegraphics[]{image-3.png}
\caption{\label{fig_2}Figure 3 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{}\includegraphics[]{image-4.png}
\caption{\label{fig_3}}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{8}\includegraphics[]{image-5.png}
\caption{\label{fig_6}8}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{}\includegraphics[]{image-6.png}
\caption{\label{fig_7}}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{10}\includegraphics[]{image-7.png}
\caption{\label{fig_8}10 Optimizing}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{}\includegraphics[]{image-8.png}
\caption{\label{figure8}}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{}\includegraphics[]{image-9.png}
\caption{\label{figure9}}\end{figure}
   \begin{figure}[htbp]
\noindent\textbf{1} \par 
\begin{longtable}{P{0.85\textwidth}}
III.\end{longtable} \par
 
\caption{\label{tab_0}Table 1 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{} \par 
\begin{longtable}{P{0.11676621160409555\textwidth}P{0.2146757679180887\textwidth}P{0.05947098976109215\textwidth}P{0.27994880546075085\textwidth}P{0.11531569965870306\textwidth}P{0.06382252559726963\textwidth}}
Manufacturer Galderma Galderma\tabcellsep Manufacturing Technology NASHA TM NASHA TM\tabcellsep Concentration (mg/mL) 20 16\tabcellsep Type Restylane® Skinboosters TM Vital Restylane®\tabcellsep Indication Fine lines. Superficial dermis\tabcellsep Year 2023\\
\tabcellsep \tabcellsep \tabcellsep Skinboosters TM Vital\tabcellsep \tabcellsep 7\\
Allergan Allergan Teoxane Merz Galderma Galderma Galderma Galderma Allergan Teoxane\tabcellsep Vycross TM Vycross TM Preserved Network CPM TM NASHA TM OBT TM / XpresHAn TM Technology OBT TM / XpresHAn TM Technology OBT TM / XpresHAn TM Technology Vycross TM Preserved Network\tabcellsep 12 15 15 20 20 20 20 20 17.5 23\tabcellsep Light Juvederm® Volite TM Juvederm® Volbella TM TEOSYAL® RHA 1 Belotero® Soft Restylane® Lido Restylane® Refyne TM Restylane® Defyne TM Restylane® Volyme TM Juvederm® Volift TM TEOSYAL® RHA 2\tabcellsep Fine and medium lines, lips; Superficial to mid dermis\tabcellsep Volume XXIII Issue VIII Version I\\
Teoxane Merz Galderma Allergan Teoxane Merz Merz\tabcellsep Preserved Network CPM TM NASHA TM Vycross® Preserved Network CPM TM CPM TM\tabcellsep 23 22.5 20 20 23 26 25.5\tabcellsep TEOSYAL® RHA 3 Restylane® Lyft TM Lido Juvederm® Voluma TM TEOSYAL® RHA 4 Belotero® Volume Belotero® Intense Belotero® Balance\tabcellsep sculpting)-subcutaneous and supraperiosteal Volume (restoration,\tabcellsep Medical Research ( D D D D )\\
\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep Global Journal of\end{longtable} \par
 
\begin{quote}
\par
F© 2023 Global Journ als\end{quote}

\caption{\label{tab_1}}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{} \par 
\begin{longtable}{P{0.6753875968992248\textwidth}P{0.019767441860465116\textwidth}P{0.059302325581395345\textwidth}P{0.03294573643410852\textwidth}P{0.03624031007751938\textwidth}P{0.02635658914728682\textwidth}}
\multicolumn{6}{l}{? Treatment Precision: Knowledge of HA rheology}\\
\multicolumn{6}{l}{aids in precise filler placement, which is crucial for}\\
\multicolumn{2}{l}{natural-looking}\tabcellsep results.\tabcellsep For\tabcellsep example,\tabcellsep lip\\
\multicolumn{6}{l}{augmentation benefits from low-viscosity HA fillers}\\
to\tabcellsep evenly\tabcellsep distribute\tabcellsep product\tabcellsep and\tabcellsep avoid\\
\multicolumn{2}{l}{overcorrection.}\tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
\multicolumn{3}{l}{? Volume Restoration:}\tabcellsep \tabcellsep \tabcellsep \end{longtable} \par
 
\caption{\label{tab_2}}\end{figure}
 		 		\backmatter  			  				\begin{bibitemlist}{1}
\bibitem[Custódio et al.]{b31}\label{b31} 	 		\textit{},  		 			Aln; Custódio 		,  		 			Ádl; Lopes 		,  		 			Fc; Figueiredo 		,  		 			Kpm; Gonçalves 		,  		 			Lcs; Contarini 		,  		 			S S Dias 		.  	 	 		\textit{SMAS e Ligamentos da face-Revisão anatômica. Aesthetic Orofacial Science}  		2021  (2) .  	 
\bibitem[Carbohydrpolym ()]{b36}\label{b36} 	 		\textit{},  		 			Carbohydrpolym 		.  		2013 Jan., v. 91, n. 1. p. .  	 
\bibitem[Lehninger et al. ()]{b30}\label{b30} 	 		\textit{},  		 			T M Lehninger 		,  		 			D L Nelson 		,  		 			M M Cox 		.  	 	 		\textit{Princípios de Bioquímica. 6ª Ed. Editora Artmed}  		2014. p. .  	 
\bibitem[De ()]{b29}\label{b29} 	 		\textit{},  		 			Escola De 		,  		 			Química 		.  		2020.  		 			Universidade Federal do Rio de Janeiro 		 	 
\bibitem[Landau (2015)]{b23}\label{b23} 	 		‘:S347-53.ÖHRLUND, Åke. Evaluation of rheometry amplitude sweep cross-over point as an index of flexibility for HA fillers’.  		 			M Landau 		.  	 	 		\textit{Journal of Cosmetics, Dermatological Sciences and Applications}  		2015 Dec. 2018. 41  (Suppl 1)  p. .  	 	 (Dermatol Surg.) 
\bibitem[Dodero et al. ()]{b2}\label{b2} 	 		‘A microrheological and rheological study of biopolymers solutions: hyaluronic acid’.  		 			A; Dodero 		,  		 			R; Williams 		,  		 			S; Gagliardi 		,  		 			S; Vicini 		,  		 			M; Alloisio 		,  		 			M Castellano 		.  	 	 		\textit{Carbohydrate Polymers}  		2018. 203 p. .  	 
\bibitem[Issa et al. (2023)]{b13}\label{b13} 	 		‘A New Cohesive High-Concentrated Hyaluronic Acid Gel Filler: Correlation between Rheological Properties and Clinical Indications’.  		 			Mc; Issa 		,  		 			A; Fogaca 		,  		 			E; Palermo 		,  		 			M; Fontes 		,  		 			H; Barud 		,  		 			A C Dametto 		.  	 	 		\textit{Journal Biomed Res Environ Sci}  		2023. Apr 06. 4  (4)  p. .  	 
\bibitem[De Boulle et al. (2013)]{b3}\label{b3} 	 		‘A Review of the Metabolism of 1,4-Butanediol Diglycidyl Ether-Crosslinked Hyaluronic Acid Dermal Fillers’.  		 			K; De Boulle 		,  		 			R; Glogau 		,  		 			T; Kono 		,  		 			M; Nathan 		,  		 			A; Roca-Martinez Tezel 		,  		 			J; Paliwal 		,  		 			S; Stroumpoulis 		,  		 			D 		.  	 	 		\textit{Dermatologic Surgery}  		2013. Dec. 39  (12)  p. .  	 
\bibitem[Faivre et al. (2021)]{b10}\label{b10} 	 		‘Advanced Concepts in Rheology for the Evaluation of Hyaluronic Acid-Based Soft Tissue Fillers’.  		 			J; Faivre 		,  		 			M; Gallet 		,  		 			E; Tremblais 		,  		 			P; Tr´evidic 		,  		 			F Bourdon 		.  	 	 		\textit{Dermatologic Surgery}  		May, 2021. 47  (5)  p. .  	 
\bibitem[Jung and Hyaluronidase ()]{b22}\label{b22} 	 		\textit{An overview of its properties, applications, and side effects. Archives of plastic surgery},  		 			H Jung 		,  		 			Hyaluronidase 		.  		2020. 47 p. .  	 
\bibitem[Kolarsick et al. ()]{b14}\label{b14} 	 		‘Anatomy and Physiology of the Ski’.  		 			Paj; Kolarsick 		,  		 			Ma; Kolarsick 		,  		 			C Goodwin 		.  	 	 		\textit{Dermatology Nurses' Association}  		2011. JULY/AUGUST. 3  (4)  p. 203.  	 
\bibitem[Kleine-Börger et al. ()]{b4}\label{b4} 	 		‘Approach to differentiate between hyaluronic acid skin quality boosters and fillers based on their physicochemical properties’.  		 			L; Kleine-Börger 		,  		 			R; Meyer 		,  		 			A; Kalies 		,  		 			M Kerscher 		.  	 	 		\textit{Cosmet Dermatol}  		2022. 21 p. .  	 
\bibitem[Costa et al. ()]{b5}\label{b5} 	 		‘Características reológicas de preenchedores dérmicos à base de ácido hialurônico antes a após passagem através de agulhas’.  		 			A; Costa 		,  		 			Lcd; Coletta 		,  		 			As; Talarico 		,  		 			Fidelis 		,  		 			Ets Mc; Weimann 		.  	 	 		\textit{Surg Cosmet Dermatol}  		2013. 5  (1)  p. .  	 
\bibitem[Sundaram and Fagien S (2015)]{b26}\label{b26} 	 		‘Cohesive Polydensified Matrix Hyaluronic Acid for Fine Lines’.  		 			H Sundaram 		,  		 			Fagien S 		.  	 	 		\textit{Plast Reconstr Surg}  		2015 Nov. 136  (5)  p. .  	 	 (Suppl) 
\bibitem[Sundaram et al. (2010)]{b34}\label{b34} 	 		‘Comparison of the Rheological Properties of Viscosity and Elasticity in Two Categories of Soft Tissue Fillers: Calcium Hydroxylapatite and Hyaluronic Acid’.  		 			H Sundaram 		,  		 			B Hema 		,  		 			B Vougts 		,  		 			K Beer 		,  		 			M Meland 		.  	 	 		\textit{Dermatologic Surgery}  		November 2010. 36 p. .  	 
\bibitem[Hong et al. (2023)]{b17}\label{b17} 	 		‘Deformation characteristics of hydrogel products based on cross-linked hyaluronic acid’.  		 			Gw; Hong 		,  		 			Hj; Moon 		,  		 			Hm; Lee 		,  		 			Dk; Kim 		,  		 			K H Lee 		.  	 	 		\textit{Journal of Cosmetic Dermatology}  		2023. April. p. .  	 
\bibitem[Ponmozhi et al. ()]{b15}\label{b15} 	 		‘Development of skin-on-a-chip platforms for different utilizations: Factors to be considered’.  		 			J; Ponmozhi 		,  		 			S; Varga-Medveczky Dhinakaran 		,  		 			Z; Fónagy 		,  		 			K; Bors 		,  		 			La ; Iván 		,  		 			K; Erdõ 		,  		 			F 		.  	 	 		\textit{Micromachines}  		2021. 12  (3)  p. .  	 
\bibitem[Ponmozhi et al. ()]{b16}\label{b16} 	 		‘Development of skin-on-a-chip platforms for different utilizations: Factors to be considered’.  		 			J; Ponmozhi 		,  		 			S; Varga-Medveczky Dhinakaran 		,  		 			Z; Fónagy 		,  		 			K; Bors 		,  		 			La ; Iván 		,  		 			K; Erd? 		,  		 			F 		.  	 	 		\textit{Micromachines}  		2021. 12  (3)  p. .  	 
\bibitem[Öhrlund ()]{b24}\label{b24} 	 		‘Evaluation of rheometry amplitude sweep cross-over point as an index of flexibility for HA fillers’.  		 			Åke Öhrlund 		.  	 	 		\textit{Journal of Cosmetics, Dermatological Sciences and Applications}  		2018. 8  (2)  p. .  	 
\bibitem[Lorenc et al. ()]{b32}\label{b32} 	 		‘Factors Affecting the Rheological Measurement of Hyaluronic Acid Gel Fillers’.  		 			Z P Lorenc 		,  		 			Å Öhrlund 		,  		 			K Edsman 		.  	 	 		\textit{J. Drugs Dermatol}  		2017. 16 p. .  	 
\bibitem[Sionkowska et al. ()]{b20}\label{b20} 	 		‘Hyaluronic acid as a component of natural polymer blends for biomedical applications: a review’.  		 			A; Sionkowska 		,  		 			M; Gadomska 		,  		 			K; Musia? 		,  		 			J Pi?tek 		.  	 	 		\textit{Molecules}  		2020. 25  (18)  p. 4035.  	 
\bibitem[Wu et al. ()]{b6}\label{b6} 	 		‘Hyaluronic Acid Basics and Rheology’.  		 			Gt; Wu 		,  		 			J; Kam 		,  		 			J D Bloom 		.  	 	 		\textit{Facial Plast Surg Clin}  		2022. 30 p. .  	 
\bibitem[Fallacara et al. ()]{b7}\label{b7} 	 		‘Hyaluronic Acid in the Third Millennium’.  		 			A; Fallacara 		,  		 			E; Baldini 		,  		 			S; Manfredini 		,  		 			S Vertuani 		.  	 	 		\textit{Polymers (Basel)}  		2018. 10  (7)  p. .  	 
\bibitem[Snetkov et al. (2020)]{b33}\label{b33} 	 		‘Hyaluronic acid: The influence of molecular weight on structural, physical, physico-chemical, and degradable properties of biopolymer’.  		 			P Snetkov 		,  		 			K Zakharova 		,  		 			S Morozkina 		,  		 			R Olekhnovich 		,  		 			M Uspenskaya 		.  	 	 		\textit{Polymers, v}  		Aug. 01, 2020. MDPI AG. 12.  	 
\bibitem[Molliard et al. ()]{b8}\label{b8} 	 		‘Key rheological properties of hyaluronic acid fillers: from tissue integration to product degradation’.  		 			Sg; Molliard 		,  		 			Jb; Bétemps 		,  		 			B; Hadjab 		,  		 			D; Topchian 		,  		 			P; Micheels 		,  		 			D Salomon 		.  	 	 		\textit{Plast. Aesthet. Res}  		2018. 5 p. 17.  	 
\bibitem[Kenne et al.]{b35}\label{b35} 	 		\textit{Modification and cross-linking parameters in hyaluronic acid hydrogels -Definitions and analytical methods},  		 			L Kenne 		,  		 			S Gohil 		,  		 			E M Nilsson 		,  		 			A Karlsson 		,  		 			D Ericsson 		,  		 			A H Kenne 		,  		 			L I Nord 		.  		 	 
\bibitem[Cohen et al. ()]{b25}\label{b25} 	 		‘Postmarket safety surveillance of delayed complications for recent FDA-approved hyaluronic acid dermal fillers’.  		 			Jl; Cohen 		,  		 			J; Hicks 		,  		 			A; Nogueira 		,  		 			V; Lane 		,  		 			B Andriopoulos 		.  	 	 		\textit{Dermatologic Surgery}  		2022. 48  (2)  p. 220.  	 
\bibitem[Lee et al. (2020)]{b12}\label{b12} 	 		‘Practical Guidelines for Hyaluronic Acid Soft-Tissue Filler Use in Facial Rejuvenation’.  		 			Won ; Lee 		,  		 			Sg; Hwang 		,  		 			W; Oh 		,  		 			Cy; Kim 		,  		 			Jl; Lee 		,  		 			E J Yang 		.  	 	 		\textit{Dermatologic Surgery}  		2020. January. 4  (6)  p. .  	 
\bibitem[Fagien et al. ()]{b19}\label{b19} 	 		\textit{Rheologic and physicochemical properties used to differentiate injectable hyaluronic acid filler products. Plastic and reconstructive surgery},  		 			S; Fagien 		,  		 			V; Bertucci 		,  		 			Ev; Grote 		,  		 			J H Mashburn 		.  		2019. 143 p. .  	 
\bibitem[Stocks et al. ()]{b9}\label{b9} 	 		‘Rheological evaluation of the physical properties of hyaluronic acid dermal fillers’.  		 			D; Stocks 		,  		 			H; Sundaram 		,  		 			J; Michaels 		,  		 			Mj; Durrani 		,  		 			Ms; Wortzman 		,  		 			D B Nelson 		.  	 	 		\textit{Journal of Drugs in Dermatology}  		2011. 10  (9)  p. .  	 
\bibitem[Zerbinati et al. ()]{b11}\label{b11} 	 		‘Rheological Investigation as Tool to Assess Physicochemical Stability of a Hyaluronic Acid Dermal Filler Cross-Linked with Polyethylene Glycol Diglycidyl Ether and Containing Calcium Hydroxyapatite’.  		 			N; Zerbinati 		,  		 			Capillo 		,  		 			S; Mc; Sommatis 		,  		 			C; Maccario 		,  		 			G; Alonci 		,  		 			R; Rauso 		,  		 			H; Galadari 		,  		 			S; Guida 		,  		 			R Mocchi 		.  	 	 		\textit{Gels}  		2022. Glycine and L-Proline. 8  (5)  p. .  	 
\bibitem[Kaya and Oytun ()]{b1}\label{b1} 	 		‘Rheological Properties of ?njectable Hyaluronic Acid Hydrogels for Soft Tissue Engineering Applications’.  		 			G; Kaya 		,  		 			F Oytun 		.  	 	 		\textit{Biointerface Resarch in Applied Chemistry}  		2021. 11  (1)  p. .  	 
\bibitem[Gatta et al. ()]{b18}\label{b18} 	 		‘Rheology and Stability in Relation to the Type/Level of Biopolymer Chemical Modification’.  		 			Al ; Gatta 		,  		 			E; Bedini 		,  		 			M; Aschettino 		,  		 			R; Finamore 		,  		 			C Hyaluronan Schiraldi 		,  		 			Hydrogels 		.  	 	 		\textit{Polymers}  		2022. 14  (12)  p. .  	 
\bibitem[De Oliveira and Fontes]{b28}\label{b28} 	 		\textit{Roadmap Tecnológico do Ácido Hialurônico. Projeto (BACHARELADO EM ENGENHARIA QUÍMICA)},  		 			Ir; De Oliveira 		,  		 			L V Fontes 		.  		 	 
\bibitem[Yeung et al. ()]{b27}\label{b27} 	 		\textit{Short-term therapeutic outcome of intra-articular high molecular weight hyaluronic acid injection for nonreducing disc displacement of the temporomandibular joint. Oral Surgery, Oral Medicine, Pathology, Oral Radiology and Endodontology},  		 			Rw; Yeung 		,  		 			Rl; Chow 		,  		 			N; Samman 		,  		 			K Chiu 		.  		2006. 102 p. .  	 
\bibitem[Abdo et al. ()]{b21}\label{b21} 	 		‘The applied anatomy of human skin: A model for regeneration’.  		 			Jm; Abdo 		,  		 			Na; Sopko 		,  		 			S M Milner 		.  	 	 		\textit{Wound Medicine}  		2020. 28 p. 100179.  	 
\bibitem[Fundarò et al. ()]{b0}\label{b0} 	 		‘The Rheology and Physicochemical Characteristics of Hyaluronic Acid Fillers: Their Clinical Implications’.  		 			Sp; Fundarò 		,  		 			G; Salti 		,  		 			Dmh; Malgapo 		,  		 			S Innocenti 		.  	 	 		\textit{Int. J. Mol. Sci}  		2022. 23  (18)  p. .  	 
\end{bibitemlist}
 			 		 	 
\end{document}
